Business Standard

Moderna to charge govts $25-$37 for Covid-19 vaccine: CEO tells paper

Moderna has said its experimental vaccine is 94.5% effective in preventing Covid-19, based on interim data from a late-stage clinical trial.

moderna, covid, vaccine, pharma, coronavirus, medicine, drugs, medical research, covid, lab
Premium

In this July 27, 2020, file photo, a nurse prepares a shot that is part of a possible Covid-19 vaccine, developed by the National Institutes of Health and Moderna Inc., in Binghamton, N.Y. (AP Photo/Hans Pennink, File)

Reuters Frankfurt
Moderna will charge governments between $25 and $37 per dose of its Covid-19 vaccine candidate, depending on the amount ordered, Chief Executive Stephane Bancel told German weekly 'Welt am Sonntag' (WamS).

"Our vaccine therefore costs about the same as a flu shot, which is between $10 and $50," he was quoted as saying.

On Monday, an EU official involved in the talks said the European Commission wanted to reach a deal with Moderna for the supply of millions of doses of its vaccine candidate for a price below $25 per dose.

"Nothing is signed yet, but we're close to a

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in